Search research articles
Contact Us
Filters
Showing results (341-350 of 355) with videos related to
Page
of 36
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2023
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
Evan M Bloch, Daniele Focosi, Shmuel Shoham, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 19, 2019
Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases
Faisa Omar, Jane E Findlay, Gemma Carfray, et al.
Human Molecular Genetics
|
November 4, 2011
A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations
Robert A Maue, Robert W Burgess, Bing Wang, et al.
JAMA Oncology
|
June 17, 2021
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
Michael A Thompson, Jeffrey P Henderson, Pankil K Shah, et al.
Cell Reports
|
November 14, 2019
Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis
Ross Dobie, John R Wilson-Kanamori, Beth E P Henderson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 3, 2020
The Effect of Convalescent Plasma Therapy on COVID-19 Patient Mortality: Systematic Review and Meta-analysis
Stephen A Klassen, Jonathon Senefeld, Patrick W Johnson, et al.
Cell Host & Microbe
|
August 1, 2020
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2
James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
SSRN
|
July 28, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2
James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2
James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
The Journal of Clinical Investigation
|
April 8, 2020
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M Bloch, Shmuel Shoham, Arturo Casadevall, et al.
Page
of 36
Search research articles
Search
Showing results (341-350 of 355) with videos related to
Sort By:
Page
of 36
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2023
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
Evan M Bloch, Daniele Focosi, Shmuel Shoham, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 19, 2019
Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases
Faisa Omar, Jane E Findlay, Gemma Carfray, et al.
Human Molecular Genetics
|
November 4, 2011
A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations
Robert A Maue, Robert W Burgess, Bing Wang, et al.
JAMA Oncology
|
June 17, 2021
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
Michael A Thompson, Jeffrey P Henderson, Pankil K Shah, et al.
Cell Reports
|
November 14, 2019
Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis
Ross Dobie, John R Wilson-Kanamori, Beth E P Henderson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 3, 2020
The Effect of Convalescent Plasma Therapy on COVID-19 Patient Mortality: Systematic Review and Meta-analysis
Stephen A Klassen, Jonathon Senefeld, Patrick W Johnson, et al.
Cell Host & Microbe
|
August 1, 2020
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2
James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
SSRN
|
July 28, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2
James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2
James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
The Journal of Clinical Investigation
|
April 8, 2020
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M Bloch, Shmuel Shoham, Arturo Casadevall, et al.
Page
of 36